Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ATG + cyclosporine vs cyclosporine + androgen in transfusion-dependent non-severe aplastic anemia
ChiCTR-IPR-17011432Phase 4Recruiting
- Sponsor
- Institute of Hematology and Blood Diseases Hospital
- Start
- May 2017
- Modality
- Small Molecules, Peptides, Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial in aplastic anemia comparing ATG + cyclosporine with Cyclosporine + androgen (2 arms). Started May 2017; status: recruiting.
02
Drugs
antithymocyte globulincyclosporine
03
Conditions
aplastic anemia
Beyond the preview
Go deeper on ChiCTR-IPR-17011432.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPR-17011432.